MIT scientists filed patent for HPBCD treatment in Alzheimer’s disease
Li-Huei Tsai, director of Picower Institute for Learning and Memory (Massachusetts Institute of Technology) and her coworkers recently filed a patent
Category: Life sciences
New US patent application on ternary CD/small guest molecule/protein interactions
Cyclolab Ltd filed a patent application (US20220282001) on cyclodextrin containing physical mixtures and inclusion complexes that show improved protein stabilizing
NASA’s Europa lander mission concept: Biosignature finding by Cyclodextrin derivatized GC column
After NASA’s Mars Curiosity rover and ESA’s Rosetta’s lander, Philae, traces of life on another extraterrestial object is expected to
Cyclodextrin based Nanosponges increased the anticancer and antimicrobial properties of the natural peptide Nisin
The considerable increase in of anticancer and antimicrobial drug resistance in the last years have created a difficult situation in
Cyclodextrin based Nanosponges and proteins
The usual thinking with cyclodextrin is about its capacity to complex small molecules, even there is a considerable bibliography about
Methyl BCD against malaria?
The researchers of College of Medicine (Pennsylvania) and Iowa University have published on ‘Dramatic Consequences of Reducing Erythrocyte Membrane Cholesterol
KLVFF oligopeptide-decorated amphiphilic cyclodextrin nanomagnets for selective amyloid beta recognition and fishing for selective amyloid beta recognition and fishing
Recognition and capture of amyloid beta is a challenging task for the early diagnosis of neurodegenerative disorders, such as Alzheimer’s
Beta-cyclodextrin filled analytical column will be carried again to Mars (by Rosalind Franklin rover).
In the near future ESA’s ExoMars mission plans to deliver the Rosalind Franklin rover onthe surface of Mars [1]. This
Cyclodextrins Exert a Ligand-like Current Inhibitory Effect on the KV1.3 Ion Channel Independent of Membrane Cholesterol Extraction
Effects of CDs exerted on cellular functions are generally thought to originate from reductions in cholesterol levels. Potential direct, ligand-like
Phospholipid/methyl-ACD complex enhancing donor blood stability
Inventors Amir Farnoud and Amid Vahedi (Ohio University, US) have filed a patent application entitled “Methods for extending the shelf-life